Log in
Enquire now
Tmunity Therapeutics

Tmunity Therapeutics

Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.

OverviewStructured DataIssuesContributors

Contents

tmunity.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Stem cell
Stem cell
Immunotherapy
Immunotherapy
Healthcare
Healthcare
Cell therapy
Cell therapy
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
...
Location
United States
United States
Philadelphia
Philadelphia
B2X
B2B
B2B
CEO
‌
Usman Azam
Founder
Dr. Carl H. June
Dr. Carl H. June
‌
Dr. Anne Chew
Dr. Bruce Levine
Dr. Bruce Levine
Dr. James L. Riley
Dr. James L. Riley
Dr. Yangbing Zhao
Dr. Yangbing Zhao
Date Incorporated
2015
Number of Employees (Ranges)
1,001 – 5,0000
Phone Number
+12159661600
Full Address
3020 Market Street, Suite 535 Philadelphia, PA 19104
Investors
University of Pennsylvania
University of Pennsylvania
Andreessen Horowitz (a16z)
Andreessen Horowitz (a16z)
The a16z Cultural Leadership Fund
The a16z Cultural Leadership Fund
Be The Match BioTherapies
Be The Match BioTherapies
Be The Match (company)
Be The Match (company)
BrightEdge Fund
BrightEdge Fund
Westlake Village BioPartners
Westlake Village BioPartners
Lilly Asia Ventures
Lilly Asia Ventures
...
Founded Date
2009
0
Total Funding Amount (USD)
424,999,948
Latest Funding Round Date
2019
Competitors
Silk Therapeutics, Inc.
Silk Therapeutics, Inc.
Sequenom
Sequenom
Business Model
Licensing
Glassdoor ID
2274744
Board of Directors
‌
Judith Li
‌
Usman Azam
‌
Garry Nicholson
‌
Patrick Gray
Sean Parker
Sean Parker
‌
Beth Seidenberg
Jeffrey Leiden
Jeffrey Leiden
Jorge Conde (investor)
Jorge Conde (investor)
Latest Funding Type
Series B
Series B
Technologies Used
CRISPR
CRISPR
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
75,000,000

Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases that is headquartered in Philadelphia, Pennsylvania. It was founded in 2015 by Carl June, Bruce Levine, Yangbing Zhao, Anne Chew, James Riley, and Bruce Blazar.

Product

The company conducts research and development around the aforementioned field of study. It uses laboratory and production facilities at the University of Pennsylvania, as well as its own production facility located near the city. It has multiple novel therapies, many of which are in the pre-clinical and clinical stages of development.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Tmunity Therapeutics

https://www.youtube.com/watch?v=oxyak9icO-Y

April 27, 2018

Tmunity Therapeutics Raises $100 Million in Series A Financing to Advance Portfolio of Next-Generation T cell Immunotherapies to Transform the Treatment of Cancer

Business Wire

https://www.businesswire.com/news/home/20180123005486/en/Tmunity-Therapeutics-Raises-100-Million-Series-Financing

Web

Tmunity Therapeutics, Inc. to Advance IND-Enabling Activities for Personalized Next-Generation Engineered T Cell Therapies with $10 Million Financing

Tmunity Therapeutics

https://www.prnewswire.com/news-releases/tmunity-therapeutics-inc-to-advance-ind-enabling-activities-for-personalized-next-generation-engineered-t-cell-therapies-with-10-million-financing-300203157.html

Web

References

Find more companies like Tmunity Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.